{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:07:27Z","timestamp":1780913247439,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology and Immunopathology"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.1006\/clin.1997.4422","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T20:18:03Z","timestamp":1033935483000},"page":"172-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Development of a Rapid Whole Blood Flow Cytometry Procedure for the Diagnosis of X-Linked Hyper-IgM Syndrome Patients and Carriers"],"prefix":"10.1006","volume":"85","author":[{"given":"Maurice R.G.","family":"O'Gorman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Paniagua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Corrochano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Pachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/clin.1997.4422_II974422C1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev.iy.10.040192.001243","article-title":"Molecular approaches to the analysis of X-linked immunodeficiencies","volume":"10","author":"Conley","year":"1992","journal-title":"Annu. Rev. Immunol."},{"key":"10.1006\/clin.1997.4422_II974422C2","first-page":"101","article-title":"Immunodeficiency with hyper IgM (HIM)","volume":"3","author":"Notarangelo","year":"1992","journal-title":"Immunodef. Rev."},{"key":"10.1006\/clin.1997.4422_II974422C3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4049\/jimmunol.158.2.977","article-title":"Cholangiopathy and tumors of the pancreas, liver and biliary tree in boys with X-linked immunodeficiency with hyper-IgM","volume":"158","author":"Hayward","year":"1997","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4422_II974422C4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJM199508173330705","article-title":"Brief Report: Correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation","volume":"17","author":"Thomas","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1997.4422_II974422C5","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.7679801","article-title":"CD40 ligand gene defects responsible for X-linked hyper IgM Syndrome","volume":"259","author":"Allen","year":"1993","journal-title":"Science"},{"key":"10.1006\/clin.1997.4422_II974422C6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0092-8674(93)90668-G","article-title":"The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome","volume":"72","author":"Arrufo","year":"1993","journal-title":"Cell"},{"key":"10.1006\/clin.1997.4422_II974422C7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/361541a0","article-title":"CD40 ligand mutations in X-linked immunodeficiency with hyper IgM","volume":"361","author":"DiSanto","year":"1993","journal-title":"Nature (London)"},{"key":"10.1006\/clin.1997.4422_II974422C8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/361539a0","article-title":"Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM","volume":"361","author":"Korth\u00e4uer","year":"1993","journal-title":"Nature (London)"},{"key":"10.1006\/clin.1997.4422_II974422C9","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1073\/pnas.90.6.2170","article-title":"Defective expression of the CD40 ligand in X chromosome linked immunoglobulin deficiency with normal or elevated IgM","volume":"90","author":"Fuleihan","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4422_II974422C10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/357080a0","article-title":"Molecular and biological characterization of a murine ligand for CD40","volume":"357","author":"Armitage","year":"1992","journal-title":"Nature (London)"},{"key":"10.1006\/clin.1997.4422_II974422C11","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1002\/j.1460-2075.1992.tb05530.x","article-title":"The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of p39 with B cell co-stimulatory activity","volume":"11","author":"Hollenbaugh","year":"1992","journal-title":"EMBO J."},{"key":"10.1006\/clin.1997.4422_II974422C12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.173.3.705","article-title":"Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigens","volume":"173","author":"Rousset","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4422_II974422C13","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.172.6.1861","article-title":"CD40 and IgE: Synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells","volume":"172","author":"Jabara","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4422_II974422C14","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4049\/jimmunol.146.6.1836","article-title":"CD40 stimulation provides an IFN independent and IL-4-dependent differentiation signal directly to human B cells for IgE production","volume":"146","author":"Zhang","year":"1991","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4422_II974422C15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1084\/jem.175.3.671","article-title":"Interleukin 10 and transforming growth factor \u03b2 cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A","volume":"175","author":"Defrance","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4422_II974422C16","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.4049\/jimmunol.150.9.3671","article-title":"Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines","volume":"150","author":"Armitage","year":"1993","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4422_II974422C17","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/342929a0","article-title":"Mechanisms of antigen-driven selection in germinal centers","volume":"342","author":"Liu","year":"1989","journal-title":"Nature (London)"},{"key":"10.1006\/clin.1997.4422_II974422C18","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1073\/pnas.89.5.1890","article-title":"Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes","volume":"89","author":"Rousset","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4422_II974422C19","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.273.5283.1864","article-title":"Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis","volume":"272","author":"Grewal","year":"1996","journal-title":"Science"},{"key":"10.1006\/clin.1997.4422_II974422C20","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1126\/science.273.5283.1862","article-title":"CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40","volume":"273","author":"Yang","year":"1996","journal-title":"Science"},{"key":"10.1006\/clin.1997.4422_II974422C21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0167-5699(96)80904-2","article-title":"CD40lbase: A database of CD40L gene mutations causing X-linked hyper-IgM syndrome","volume":"17","author":"Notarangelo","year":"1996","journal-title":"Immunol. Today"},{"key":"10.1006\/clin.1997.4422_II974422C22","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1172\/JCI117476","article-title":"Hyper IgM Syndrome associated with defective CD40-mediated B cell activation","volume":"94","author":"Conley","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1997.4422_II974422C23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1073\/pnas.91.3.1099","article-title":"CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency","volume":"91","author":"Farrington","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4422_II974422C24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1128\/cdli.2.2.227-232.1995","article-title":"Rapid whole-blood flow cytometry assay for diagnosis of chronic granulomatous disease","volume":"2","author":"O'Gorman","year":"1995","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1006\/clin.1997.4422_II974422C25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1749-6632.1993.tb38807.x","article-title":"A rapid whole blood lysis technique for the diagnosis of moderate or severe leukocye adhesion deficiency (LAD)","volume":"677","author":"O'Gorman","year":"1993","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1006\/clin.1997.4422_II974422C26","first-page":"S474","article-title":"X-linked Hyper IgM syndrome (XHIM) mutation analysis, CD40L function and clinical phenotype","volume":"99","author":"Seyama","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1006\/clin.1997.4422_II974422C27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1172\/JCI117677","article-title":"Diminished expression of CD40 ligand by activated neonatal T cells","volume":"95","author":"Nonoyama","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1997.4422_II974422C28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1542\/peds.54.4.508","article-title":"Correction of neutropenia associated with dysgammagloulinemia","volume":"54","author":"Rieger","year":"1974","journal-title":"Pediatrics"},{"key":"10.1006\/clin.1997.4422_II974422C29","first-page":"387A","article-title":"Mutational analysis of X-linked hyper-IgM syndrome","volume":"44","author":"Almeida","year":"1996","journal-title":"J. Invest. Med."}],"container-title":["Clinical Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122997944226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122997944226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:10:57Z","timestamp":1758762657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090122997944226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["S0090122997944226"],"URL":"https:\/\/doi.org\/10.1006\/clin.1997.4422","relation":{},"ISSN":["0090-1229"],"issn-type":[{"value":"0090-1229","type":"print"}],"subject":[],"published":{"date-parts":[[1997,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a Rapid Whole Blood Flow Cytometry Procedure for the Diagnosis of X-Linked Hyper-IgM Syndrome Patients and Carriers","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/clin.1997.4422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1997 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}